Predictors of Effectiveness of Platelet-Rich Plasma Therapy forKnee Osteoarthritis: A Retrospective Cohort Study

FDA cleared 510(k) Class II medical device: Tropocells PRP is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK110035